A carregar...

A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patients

BACKGROUND: Multiple sclerosis (MS) is a chronic disease characterized by demyelination, glial activation and axonal degeneration in the central nervous system. At the present, there is no certain remedy for this disease. However, available therapies often attenuate disease progress. METHODS: This s...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Transl Med
Main Authors: Mazdeh, Mehrdokht, Kargar Monhaser, Shahriar, Taheri, Mohammad, Ghafouri-Fard, Soudeh
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6451934/
https://ncbi.nlm.nih.gov/pubmed/30957197
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40169-019-0228-7
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!